Lecanemab ,Leqembi ,Amyloid-β (Aβ) ,BAN2401 ,Anti-amyloid monoclonal antibody ,Neurology biologic / Alzheimer's disease biologic ,Monoclonal Antibody ,CAS No.1260393-98-3
Lecanemab ,Leqembi ,Amyloid-β (Aβ) ,BAN2401 ,Anti-amyloid monoclonal antibody ,Neurology biologic / Alzheimer's disease biologic ,Monoclonal Antibody ,CAS No.1260393-98-3
Trade Name
Leqembi
Target
Amyloid-β (Aβ)
Molecular Type
Monoclonal Antibody
Sales In 2025 (Millions Of USD)
500(estimate)
Product Description
Detailed Specifications & Features
Trade Name : Leqembi
Target : Amyloid-β (Aβ)
Molecular Type : Monoclonal Antibody
Sales in 2025 (Millions of USD) : 500(estimate)
All detailed product information shall be subject to the issued final COA.
Should you need further in-depth documentation for this item, kindly get in touch with us.
